Page last updated: 2024-08-24

valsartan and Blood Clot

valsartan has been researched along with Blood Clot in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Foster, H; Foster, R; Philippou, H; Wilson, C	1
Cai, F; Chen, XN; Jiang, MH; Shen, WF; Wang, HY; Wang, LJ; Wang, XF; Wu, F; Yang, Q; Zhang, FR	1
Casado, S; Gómez, J; Jiménez, A; Lopez-Bloya, A; López-Farré, A; Montón, M; Núñez, A; Rico, L; Sánchez de Miguel, L	1

Reviews

1 review(s) available for valsartan and Blood Clot

Article	Year
Angiotensin II AT(1) receptor antagonists and platelet activation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Thrombosis; Humans; Losartan; P-Selectin; Platelet Activation; Platelet Aggregation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Thromboxane; Tetrazoles; Thrombosis; Thromboxane A2; Valine; Valsartan	2001

Article

Year

Angiotensin II AT(1) receptor antagonists and platelet activation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Thrombosis; Humans; Losartan; P-Selectin; Platelet Activation; Platelet Aggregation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Thromboxane; Tetrazoles; Thrombosis; Thromboxane A2; Valine; Valsartan

2001

Trials

1 trial(s) available for valsartan and Blood Clot

Article	Year
Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension. Chinese medical journal, 2015, Jan-20, Volume: 128, Issue:2 Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Blood Platelets; Blotting, Western; Cell Line; Cyclooxygenase 2; Female; Humans; Hypertension; Male; Platelet Aggregation; Real-Time Polymerase Chain Reaction; Tetrazoles; Thrombosis; Thromboxane B2; Valine; Valsartan	2015

Article

Year

Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.

Chinese medical journal, 2015, Jan-20, Volume: 128, Issue:2

Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Blood Platelets; Blotting, Western; Cell Line; Cyclooxygenase 2; Female; Humans; Hypertension; Male; Platelet Aggregation; Real-Time Polymerase Chain Reaction; Tetrazoles; Thrombosis; Thromboxane B2; Valine; Valsartan

2015

Other Studies

1 other study(ies) available for valsartan and Blood Clot

Article	Year
Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis. Journal of medicinal chemistry, 2020, 11-12, Volume: 63, Issue:21 Topics: Binding Sites; Biological Products; Humans; Ligands; Losartan; Molecular Dynamics Simulation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Signal Transduction; Small Molecule Libraries; Thrombosis	2020